Pharmovital ApS: Financial statements 2015
CVR: 27206506
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
Pharmovital ApS (CVR 27206506) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 1,808,633 and a net result of DKK 481,325 compared with DKK -942,091 the year before. That is an increase of 4% compared with the year before. Equity in the 2015 report amounted to DKK 817,505. The solvency ratio was 24.3%.
- Gross Profit
- DKK 1,808,633
- Profit/Loss
- DKK 481,325
- Equity
- DKK 817,505
- Total Assets
- DKK 3,367,562
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 1.8 mio. | 481 t. | 818 t. | - |
| 2014 | - | 1.7 mio. | -942 t. | 336 t. | 2 |
| 2013 | - | 1.5 mio. | 481 t. | 1.3 mio. | - |
Official annual report
How creditworthy is Pharmovital ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of February 28, 2015, PIASTER REVISORERNE, GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Pharmovital ApS.
As of February 28, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Pharmovital ApS.
About Pharmovital ApS
Pharmovital ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2003. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named GALLIVIT ApS and ApS KBIL 17 NR. 1578. The management consists of Kristian Krogh and Eskil Krogh. The company is owned by Eskro Holding ApS and Kr. Krogh Holding ApS. The company has 6 employees (2026). In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. Equity in the 2026 report amounted to DKK 8,743,173.